NEW YORK (AP) – U.S. stocks are lower Thursday as EpiPen maker Mylan and other drug companies face scrutiny over increases in product prices. Oil prices are little changed after a big surge a day ago, but companies that drill for oil are climbing. A slide in high-dividend stocks like utilities and real estate companies is also pulling the market lower.
KEEPING SCORE: The Dow Jones industrial average lost 64 points, or 0.4 percent, to 18,275 as of 11:20 a.m. Eastern time. The Standard & Poor’s 500 slipped 7 points, or 0.3 percent, to 2,164. The Nasdaq composite fell 29 points, or 0.5 percent, to 5,289.
OIL PRICES: Oil prices inched higher Thursday after a 5 percent surge the day before. Energy prices had jumped after the nations of OPEC, which collectively produce more than third of the world’s oil, agreed to a small cut in production. The decision was a surprise, but something investors had long hoped for. The deal won’t be finalized until November.
U.S. crude picked up 38 cents to $47.43 a barrel in New York. Brent crude, the international benchmark, added 32 cents to $49.56 a barrel in London.
GUSHER: Companies that drill for oil rose sharply as investors expected them to benefit from higher prices for crude. Devon Energy added $1.81, or 4.3 percent, to $43.39. Companies that provide rigs and other equipment to drillers also rose as investors expected that higher prices will encourage more drilling. Helmrich & Payne rose $3.11, or 5 percent, to $65.89. But companies that refine oil fell on the prospect they will have to pay more money for the oil they refine. Marathon Petroleum fell $2.40, or 5.6 percent, to $40.24 and Valero Energy lost $2.53, or 4.6 percent, to $52.58.
